Publications by authors named "K Mara"
Rationale & Objective: Remote patient monitoring (RPM) could improve the quality and efficiency of acute kidney injury (AKI) survivor care. This study described our experience with AKI RPM and characterized its effectiveness.
Study Design: A cohort study matched 1:3 to historical controls.
Educational and psychological research often involves comparing motivation across groups. It is critical to ensure that observed differences in motivation are true variations by group, not due to measurement biases. With a diverse sample of undergraduate students (N = 2200), this study measured internal consistency and gathered validity evidence based on the internal structure of five motivation scales.
View Article and Find Full Text PDFArticle Synopsis
- Intraductal papillary mucinous neoplasms (IPMNs) are common pancreatic cysts often found incidentally in liver transplant recipients, but their risk of progressing to cancer and the effects of immunosuppression are not well understood.
- A study at Mayo Clinic over 13 years reviewed 146 liver transplant patients for suspected IPMNs and found only 7 cases of progression (2 with cancer and 5 with concerning features) during an average follow-up of 66.6 months.
- Results indicated that the type of immunosuppression used did not influence IPMN progression, though factors like combined kidney-liver transplant and prior cholangiocarcinoma were associated, suggesting that larger studies are needed
Objective: Menopause symptoms affect quality of life and financial well-being but are often unaddressed in primary care clinics. Therefore, we evaluated the extent of menopause symptom documentation in electronic health records (EHRs) by primary health care professionals.
Methods: We retrospectively reviewed adult women who reported moderate or higher vasomotor symptoms on a Mayo Clinic survey conducted from March 1, 2021, through June 30, 2021.
Background And Aim: Renal dysfunction is associated with poor outcomes in patients with coronavirus disease 2019 (COVID-19). In an effort to improve outcomes, intravenous remdesivir has been broadly used for the treatment of COVID-19 even in patients with low estimated glomerular filtration rate (eGFR). Our study assessed the residual risk of outcomes of patients with low eGFR despite treatment with remdesivir for COVID-19, during a timeframe prior to the expanded label across all levels of renal function.
View Article and Find Full Text PDF